Explore Hers: business model, clinical structure, and how the program compares to PlexusDx Weight Management Protocols. Independent editorial review of HERS.

An editorial review of Hers: program structure, compounded-pharmacy pathway, pricing, and safety considerations. Independent editorial review of HERS.

An editorial review of Hers — program structure, compounded-pharmacy pathway, pricing, and safety considerations. Independent review of HERS.

An editorial review of Hers — program overview, medication approach, pricing, and the genetic variable the brand does not address.

An editorial review of Hers, covering how the GLP-1 program works, eligibility, and how it compares to PlexusDx Weight Management Protocols.

An editorial review of Fridays — how the weight loss program is structured, cost, compounded pathway, and alternatives.

An editorial review of Fridays — how the program prescribes the compound, pricing, and the PlexusDx alternative.

A fair look at Fridays: program structure, compounded-pharmacy pathway, pricing, and safety considerations. Independent editorial review of Fridays.

Explore Fridays, covering program structure, GLP-1 medication options, pricing tiers, and compounded-pharmacy pathway. An independent editorial look at Fridays.

Found reviewed: program model, medication options, eligibility, pricing, and editorial context. Fair editorial context for readers researching Found.

A fair look at Eden: program model, medication options, eligibility, pricing, and editorial context. Independent editorial review of Eden.

Explore Eden: how the program prescribes the compound, pricing, and the PlexusDx alternative. Independent editorial review of Eden.

An editorial review of Eden — how the GLP-1 program works, eligibility, and how it compares to PlexusDx Weight Management Protocols.

An editorial review of Brello — how the weight loss program is structured, cost, compounded pathway, and alternatives.

Understand Brello, covering how the program prescribes the compound, pricing, and the PlexusDx alternative. An independent editorial look at Brello.

An editorial review of Brello — program structure, GLP-1 medication options, pricing tiers, and compounded-pharmacy pathway.

An editorial review of Ro — how the weight loss program is structured, cost, compounded pathway, and alternatives.

An editorial review of Ro — how the GLP-1 program works, eligibility, and how it compares to PlexusDx Weight Management Protocols.

An editorial review of Noom — program structure, GLP-1 medication options, pricing tiers, and compounded-pharmacy pathway.

Understand Hims: how the weight loss program is structured, cost, compounded pathway, and alternatives. Independent editorial review for HIMS.

Hers reviewed: program model, medication options, eligibility, pricing, and editorial context. Fair editorial context for readers researching HERS.

Embody GLP-1 review vs PlexusDx: Embody locks semaglutide refills at $299/month (~$3,438/year) after the intro tier; PlexusDx Microdose GLP-1 Protocol is $129/mo flat ($1,548/year) and Semaglutide Injection is $179–$229/mo. Both use compounded medications; PlexusDx adds the Precision Peptide Genetic Test for genetics-informed dosing.

Strut Health review: oral semaglutide lozenges $99-$149/mo, injectable $149-$289/mo, FDA warning letter Feb 2026, D+ BBB rating, cancellation friction. Compared to PlexusDx Microdose GLP-1 ($129/mo), Semaglutide Injection ($179-$229/mo), and Tirzepatide Injection ($229-$309/mo) with the optional Precision Peptide Genetic Test for dose personalization.

Henry charges $297/month flat for compounded semaglutide or tirzepatide with consultation and shipping included — comprehensive but mid-to-upper tier. We compare Henry's annualized cost ($3,564/year) against PlexusDx Weight Management Protocols ($1,548–$3,900/year), explain the compounded vs FDA-approved branded medication question, and walk through dose flexibility and genetic baseline differences so you can pick the right cash-pay GLP-1 route.

DudeMeds advertises compounded semaglutide and tirzepatide from $149+/month with no membership fee, but dose-escalation pricing is not consistently published and review depth is still thin. This review compares DudeMeds against PlexusDx Weight Management Protocols (Microdose GLP-1 at $129/mo flat, Semaglutide Injection $179–$229/mo, Tirzepatide Injection $229–$309/mo) and the optional Precision Peptide Genetic Test for genetic-informed titration.

Sprout Health offers compounded semaglutide at $249/mo and compounded tirzepatide at $299/mo across 44 states with documented slow customer service. Compare Sprout's pricing, state coverage, FDA-approval status, and clinical model with PlexusDx Weight Management Protocols ($129-$309/mo, all 50 states, optional Precision Peptide Genetic Test).

Honest review of Willow GLP-1 patient reviews, pricing ($299-$549/mo), compounded sourcing, and how PlexusDx Weight Management Protocols compare on cost, formulary, state availability, and the optional Precision Peptide Genetic Test for individualized dose decisions.

Synergy Rx GLP-1 review: real maintenance pricing, compounded vs branded medication source, cash-pay alternatives, and how PlexusDx Weight Management Protocols compare on price, delivery format, and genetic baseline.

An honest, verified review of Skinny Rx tirzepatide tablets — the $299/month buccal-dissolve compounded product, the February 2026 FDA warning letter, and the actual evidence picture for any oral tirzepatide formulation — with a feature-by-feature comparison to PlexusDx Tirzepatide Oral Protocol ($229–$509/mo, 5mg to 25mg daily across seven dose levels) as the cash-pay alternative.

MEDVi sells two different oral GLP-1 products under one banner: a compounded semaglutide tablet from $249/month and a Wegovy pill route at $99/month membership plus medication. We unpack the pricing, the FDA regulatory status, the 72-hour cancellation rule, and where PlexusDx Semaglutide Oral ($209/mo+) and Microdose GLP-1 Protocol ($129/mo flat) fit for cash-pay readers who want a non-injection GLP-1.